Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 12,320
-320 (-2.53%)
At close: Jul 18, 2025, 3:30 PM KST
Y-Biologics Revenue
Y-Biologics had revenue of 407.20M KRW in the quarter ending March 31, 2025, a decrease of -64.36%. This brings the company's revenue in the last twelve months to 5.03B, up 23.30% year-over-year. In the year 2024, Y-Biologics had annual revenue of 5.76B with 65.64% growth.
Revenue (ttm)
5.03B
Revenue Growth
+23.30%
P/S Ratio
36.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
184.17B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| KB Financial Group | 14.93T |